Windtree Therapeutics, Inc. (WINT) Misses Q2 EPS by 2091c
Windtree Therapeutics, Inc. (NASDAQ: WINT) reported Q2 EPS of ($20.91).
For earnings history and earnings-related data on Windtree Therapeutics, Inc. (WINT) click here.
Windtree Therapeutics, Inc. (NASDAQ: WINT) reported Q2 EPS of ($20.91).
For earnings history and earnings-related data on Windtree Therapeutics, Inc. (WINT) click here.